The European Union has prepared a new list of retaliatory tariffs worth €72 billion ($84 billion) on U.S. goods, including ...

Ford's low valuation and strong FCF yield make it intriguing, but profitability and high debt remain concerns. The company is ...

Vertex Pharmaceuticals (VRTX) has reached a broad reimbursement agreement with NHS England for Vertex’s cystic fibrosis medicine, Alyftrek (deutivacaftor/tezacaftor/vanzacaftor).

Broadcom continues to benefit from big tech's AI spending and diversification of its business. Find out why AVGO stock is a ...

The United States is imposing antidumping duties on the majority of fresh tomato imports from Mexico, the U.S. Commerce ...

The Space NK acquisition is a strategic, capital-light entry into Europe, expanding Ulta Beauty’s growth runway. Read more on ULTA stock here.

Gemini 2.5 Pro outperforms peers with one million-token context windows, doubling soon, embedding deeply into Search and ...

Ares Capital's Q1 2025 results show revenue growth, controlled expenses, and improving margins. Read why I rate ARCC stock a ...

ZIM Integrated's latest dividend declaration and Dividend Cushion Ratio indicate adequate near-term dividend coverage. Read ...

Waters Corp.'s $17.5B merger with BD Biosciences aims to double revenue but raises risks. Read here for an investment ...

PIMCO Dynamic Income Fund (PDI) is a Buy for high-yield investors, with a 13.9% yield and potential gains from anticipated ...

Avery Dennison's Q1 2025 results show mixed outcomes with growth in Solutions Group and steady shareholder rewards. Read more ...